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Abstract 
Purpose: To evaluate the healing activity of water ginseng (Panax ginseng C.A. Meyer) polysaccharide 
(WGP) in vivo.  
Methods: Mice were divided into four groups: group 1 was the control, and groups 2–4 were treated 
with WGP (15 mg or 30 mg) or mouse epidermal growth factor (mEGF, 0.1 mL, 2000 IU/mL), 
respectively. Full-thickness excision wounds were made on the back of each mouse. Wound areas were 
imaged, and wound contraction (%) was calculated. Histological observation and analysis of collagen 
content were performed using standard biochemical methods.  
Results: Wound contraction and the period of epithelialization in WGP groups were significantly 
different from those of control. The 30 mg WGP group showed 85.0 % wound healing, while control 
group showed only 65.8 % wound healing (p < 0.001) 10 days after the operation. WGP also promoted 
the formation of collagen in a dose-dependent manner. Histological examination confirmed that 
fibroblasts and new blood vessels were more abundant in WGP group than in control group.  
Conclusion: Topical application of WGP stimulates wound contraction and accelerates healing. This 
may be due to the ability of WGP to enhance the functions of macrophages and myeloid hematopoietic 
cells, resulting in increased fibroblast division, collagen synthesis, and production of blood cells during 
wound healing. 
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The skin plays a crucial role in maintaining 
homeostasis. Wounds are breaks in the epithelial 
integrity of the skin, and may result in disruption 
of the structure and function of the underlying 
normal tissue, as well as other complications, 
including bacterial infections and fluid loss. 
Therefore, continuity of the skin must be 
expeditiously restored [1]. Wound healing 
involves a dynamic, well-orchestrated series of 
events that involves many different types of cells 
and inflammatory mediators such as cytokines 
[2,3]. Macrophages are essential for the 
transition from the inflammation to repair phases, 
and help orchestrate fibroblast proliferation and 
the removal of fibrin. Macrophages also secrete 
tumor necrosis factors (TNFs), which stimulate 
both fibroblasts and keratinocytes [4]. Fibroblasts 
proliferate and produce matrix proteins, including 
collagen, which help construct a new 
extracellular matrix that supports further 
ingrowths of cells and is essential for the repair 
process. Wound contraction occurs via an 
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interaction between fibroblasts and the 
surrounding extracellular matrix [3]. 
 
Polysaccharides from plant extracts are 
important macromolecules that have been used 
as therapeutic agents in both animals and 
humans. In traditional medicine, polysaccharide-
containing plant extracts are widely employed for 
the treatment of skin and epithelium wounds and 
mucous membrane irritation [5]. Ginseng has 
been used for more than 2000 years, and is 
generally considered a longevity medicine [6]. 
Chinese traditional medicine textbooks describe 
its ability to tonify blood, expel toxins, promote 
skin regeneration, prevent infections, and 
regulate the immune system, among other 
actions [7–11]. Ginseng extracts have also been 
used clinically as a topical treatment for atopic 
suppurative dermatitis, wounds, and skin 
inflammation. Ginseng polysaccharides are 
major active components of ginseng [12,13]. 
Numerous studies on the pharmacology of WGP 
have shown that they induce the secretion of 
TNFs, enhance the activity of T cells [12,14], 
increase the function of mononuclear 
phagocytes, and promote the transformation of 
mononuclear phagocytes into macrophages [15]. 
WGP also play an important role in regulating the 
proliferation and differentiation of myeloid 
hematopoietic cells, which may be related to 
increases in hepatocyte growth factor (HGF) 
secreted by stromal cells in hematopoietic 
microenvironments to promote the production of 
blood cells [16,17]. However, studies on the 
effects of WGP on wound repair are lacking. 
 
Therefore, we investigated the effects of WGP on 
the healing of full-thickness skin wounds in mice, 
as well as collagen deposition and the 






WGP was prepared according to a previously 
reported method [18]. Dry ginseng root was 
heated in distilled water at 100 °C for 3 – 4 h. 
The extract filtrate was condensed in a rotary 
evaporator and mixed with cold absolute ethanol. 
The polysaccharide precipitates were collected 
from the alcohol phase by centrifugation (4500 
rpm, 10 min). To obtain a pure product, the 
polysaccharides were deproteinized using Sevag 
reagent (n-butanol:chloroform = 1:4), starches 
were removed using α-amylase, and the 
polysaccharides were precipitated with 75 % 
ethanol. After dialysis using distilled water, 
followed by lyophilization, WGP was obtained 
consisting of 84.4 % (w/w) sugar and 34.6 % 
(w/w) uronic acid. The monosaccharide 
component consisted of 41.2 % galacturonic 
acid, 20.1 % galactose, 16.1 % glucose, 15.8 % 
arabinose, 2.7 % rhamnose, and 2.2 % 
mannose. Before using them, they were 
prepared as gels by dissolving 15 mg or 30 mg 
lyophilized powder in 0.1 mL distilled water. 
mEGF was purchased from Sigma Co., USA. 
Paraffin was kindly provided by Leica. Co. Ltd., 
Germany. A hydroxyproline assay kit was 
purchased from Sigma Co., USA. Slide glass 
was supplied by Matsunami, Japan. All 




Forty male and female ICR mice weighing 28–32 
g were provided by the Animal Center of Jilin 
University. Animals were acclimatized for a week 
in a room with a controlled temperature of 23 ± 2 
°C and a relative humidity of 30–60 %, and given 
free access to standard laboratory diet and water 
prior to the investigation. All animal experiments 
were approved by the Animal Experimental 
Ethics Committee of Northeast Normal University 
(approval ref no. 20130110) and carried out in 
strict accordance with the recommendations in 
the Guide for the Care and Use of Laboratory 
Animals of the National Institutes of Health [19]. 
 
Excision wound model  
 
The mice were divided into four groups of forty 
animals: group 1 was the control, and groups 2–
4 were treated with WGP (15 mg), WGP (30 mg), 
or mEGF (0.1 mL, 2000 IU/mL), respectively. 
The animals were anesthetized with ether, the 
dorsal hair was clipped, and one full-thickness, 
round wound about 9 mm in diameter was 
created on the back of each mouse using a 
sharp pair of scissors and a scalpel. Then WGP 
was applied to the wounds at a dose of 15 mg or 
30 mg. The control wound was treated with 
sterile cotton gauze during the postoperative 
period. After surgery, the animals were kept 
individually in separate cages. The progressive 
changes in wound area were measured in mm2 
by tracing the wound boundaries on a plastic 
sheet every other day. Tracings were digitized by 
scanning and wound areas were quantified using 
Image J software. Wound contraction was 
expressed as the percentage reduction in wound 
size, as formulated in Eq 1. 
 
PW = {(S0– SN)/S0} × 100 ……………………. (1) 
 
where PW is the percentage of wound 
contraction, S0 (mm2) is the primary wound area, 
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 and SN (mm2) is the wound area on day N. 
 
Biochemical assays  
 
Collagen is an important component of wound 
healing, as it fills in tissue defects. 
Hydroxyproline exists almost exclusively in 
collagen [18] and thus is a sensitive biochemical 
marker that reflects changes in collagen fibers. 
Concentrations of hydroxyproline and collagen 
were estimated using the traditional acid 
hydrolysis method [20,21]. Excised granulation 
tissues were weighed, defatted in a 
chloroform:methanol mixture (2:1, v:v), 
hydrolyzed in 6.0 N HCl for 6 h at 110 °C, and 
evaporated to dryness. The hydrolysate was 
neutralized to pH 6.0–6.8 and subjected to 
chloramine-T oxidation. Then the test tubes were 
placed in a water bath at 60 °C for 25 min. The 
reaction was terminated by adding 1 mL (0.4 M) 
perchloric acid, the color was developed by 
adding 1 mL paradimethyl aminobenzaldehyde 
(PDAB), and the assay was read at 557 nm 
using a spectrophotometer. The collagen content 
was estimated from the hydroxyproline 




Skin including the wound was carefully excised 
1, 3, 7, and 10 days after injury and fixed in 4 % 
formaldehyde, embedded in paraffin, and cut in 
4–6 μm increments with a microtome. The 
sections were made perpendicular to the 
anterior–posterior axis and perpendicular to the 
surface of the wound. The sections were 
positioned on a slide, and stained with 
hematoxylin-eosin (HE) reagent. Representative 
sections from each wound were quantitatively 
evaluated for wound width, wound cellularity, 
neovascularization, and tissue granulation. 
 
Statistical analysis  
 
All data are expressed as mean ± SD. Statistical 
analyses were performed using one-way ANOVA 
(SPSS Statistics 17.0). Differences were 




In vivo observation 
 
There was no mortality in the study. In vivo 
observations were limited to injured lesions, body 
weight, and diet. The lesions resulted in local 
redness and swelling and moist fluid exudation 
from the subcutaneous tissues and wound edges 
in both the control and study groups. Three days 
after surgery, wounds treated with WGP/EGF 
had no effusion and new granulation had begun 
to cover part of the wound, while the control 
wounds still had some effusion and no 
granulation (Figure 1). WGP/EGF treatment 
considerably decreased inflammatory cells in the 
early phase of healing. There were no 
differences in body weight or diet between the 
control and study groups. 
 
Healing time, wound area, and wound 
contraction 
 
To evaluate the effects of WGP on wound 
healing, healing time and closure were observed. 
Healing time was significantly slower in controls 
than in the treatment groups (Table 1). WGP 
treatment accelerated wound contraction and 
shortened the healing time by 2–3 days. In 
addition, by day 7, wounds treated with 30 mg 
WGP had more epithelial tissue than the controls 
(Figure 1). 
 
Table 1: Mean healing time of wounds (n = 10) 
 
Group Wound healing time (day) 
1 16.2 ± 1.69 
2 13.7 ± 2.11* 
3 13.1 ± 1.51** 
4 12.6 ± 3.23** 
Values are mean ± SD (n = 10); *p ＜ 0.05 **p ＜ 0.01 
***p ＜ 0.001 
 
As shown in Figure 2, treatment of wounds with 
15 mg and 30 mg WGP resulted in a higher rate 
of wound contraction, and the 30 mg WGP group 
showed a faster closing rate. The rate of wound 
contraction in control mice was 30.2 to 42.2 % 
from day 3 to day 7 and 65.8 to 85.3 % from day 
10 to day 14; complete epithelialization and 
healing were observed on day 16. Mice treated 
with 30 mg WGP showed increased wound 
contraction from 40.5 % on day 3 to 57.4 % on 
day 7 and 85.0 to 95.0 % from day 10 to day 14. 
Complete epithelialization and healing were 
observed on day 13. The percent of wound 
contraction in mice treated with mEGF was 49.3 
% on day 3, 66.4 % on day 7, and 85.1 % on day 
10 to 98.3 % on day 14, which was similar to the 
30 mg WGP group. 
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Figure 1: Photographic representation of a wound contraction area on different post-excision days in each group 
of mice at 3, 7, 10, and 14 days post-injury 
 
 
Figure 2: Effect of different doses of WGP on the contraction percentage of a full-thickness wound in mice. Data 
are given as mean ± SD for 10 animals in each group. Statistically significant results are indicated as * at p < 
0.05; control = ◆; WGP (15 mg) = □; WGP (30 mg) = ▲; EGF = × 
 
 
Figure 3. Effects of topical WGP on hydroxyproline content at 3, 7, 10, and 14 days post-injury. Values are mean 
± SD. *P < 0.05, **P < 0.01, ***P < 0.001 
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Figure 4. Histopathology of wounds stained with H&E (100×). (A) WGP-treated mice showing large amounts of 
inflammatory cells (black arrow) on day 1. (B) Control mice showing a small number of inflammatory cells on day 
1. (C) WGP-treated mice showing neovasculature and new blood cells in granulation tissue (black arrow) on day 
3. (D) WGP-treated mice showing large amounts of granulation tissue, a small number of inflammatory cells, and 
extensive fibrosis (black arrow) on day 7 
 
Biochemical profile  
 
Figure 3 presents changes in collagen content. 
The maximum concentration of collagen in 
wounds from all groups was observed on day 10 
post-injury. Both concentrations of WGP resulted 
in a significantly higher level of collagen 
compared to controls at all time points (p < 0.01). 
Then the concentration gradually decreased from 
day 10 and returned to the level recorded on day 
7 in all experimental groups. However, the 
wounds from animals in groups 2 and 3, which 
were treated with WGP, had a higher level of 
collagen than those in group 1 throughout the 
treatment (p < 0.05, Figure 3). 
 
Histological features  
 
Histological examination of wounds supported 
the observation that WGP accelerated healing. A 
significant increase in inflammatory cell 
infiltration and macrophage phagocytosis was 
found in WGP-treated wounds compared to 
control wounds after 1 day (Figure 4A,B). Skin 
wounds treated with WGP showed better healing 
than control mice, including observable 
granulation and the formation of a stratified 
epithelium (Figure 4D). Furthermore, 
neovasculature in granulation tissue progressed 
faster in WGP-treated mice compared to control 
mice (Figure 4C). By day 10 after injury, WGP-
treated wounds were almost completely 
epithelialized and almost all necrotic tissues had 
been replaced by new granulation. The wounds 





We evaluated the wound-healing potential of 
WGP applied to full-thickness wounds in mice. 
Numerous studies have shown that the topical 
application of WGP can stimulate wound 
contraction and improve healing [23,26–28]. We 
found that the application of 15 mg or 30 mg 
WGP induced significant wound healing from 
days 3 to 14 after injury compared to the control 
group. Wound closure in the 30 mg WGP group 
was similar to that in the EGF-treated group, and 
healing was significantly higher than in controls 
(40.5 vs. 30.2 %, 57.4 vs. 42.2 %, 85.0 vs. 65.8 
%, and 95.0 vs. 85.3 % on days 3, 7, 10, and 14, 
respectively). The maximum difference between 
the WGP groups and controls was recorded 10 
days after injury (Figure 2). Healing time was 
also shorter in WGP-treated mice than in 
controls. Together, these results suggest that 
WGP can accelerate wound contraction, and that 
higher doses have a stronger effect. 
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The healing process begins with cell proliferation. 
The main cells that trigger the process are 
macrophages that remove foreign bodies and 
direct the development of granulation tissue. 
Then fibroblasts and endothelial cells migrate 
towards the injured area, increasing tissue 
permeability and the production of collagen fiber 
[22]. Wound contraction occurs through the 
interaction between fibroblasts and the 
surrounding extracellular matrix. Histological 
examinations confirmed that fibroblasts were 
abundant 3 days after injury in the WGP-treated 
groups. During the phase in which fibroblasts are 
attracted to the wounds, angiogenesis occurs 
from blood vessels near the injury. In WGP-
treated groups, new blood vessels and soft, pink 
granulation tissue were well established. In 
contrast, in the control group, fibroblast cell 
proliferation was slow and new blood vessels 
and granulation tissue were not obvious 3 days 
after injury. These effects may be due to the 
increase in HGF secretion from stromal cells 
induced by WGPs in the hematopoietic 
microenvironment, which promotes the 
development of blood cells [13]. HGF is a key 
growth factor involved in wound healing, and it 
plays an important role in neovascularization and 
the formation of granulation tissue [1]. These 
findings suggest that WGP accelerate wound 
closure in mice to a similar extent as EGF.  
 
Three days post-injury, control wounds were 
obviously red and swollen, with inflammatory 
exudation. In contrast, WGP-treated wounds 
were almost completely dry and covered with 
granulation tissue with no obvious swelling 
(Figure 1) [2]. These results suggest that WGP 
can increase the function of the mononuclear 
phagocyte system [14], which is an important 
process in wound healing. In the early phases of 
wound healing, monocytes are recruited to the 
wound by growth factors, and monocyte chemo-
attractant proteins adhere to the provisional fibrin 
plug matrix via integrin receptors before 
transforming into macrophages. Macrophages 
perform phagocytosis to destroy invading 
bacteria and clear debris and necrotic tissue [3]. 
Therefore, WGP treatment decreased the 
inflammatory response at the wound site (Figure 
4A). This effect could also be related to the 
antimicrobial traits of WGP [20,22]. 
 
Hydroxyproline is an amino acid that is essential 
for the synthesis of collagen fibers. For this 
reason, its levels are used as an indicator of 
collagen content. Hydroxyproline levels in 
granulation tissues increased in all treatment 
groups from days 3 to 10, and then returned to 




Application of WGP to open wounds induces 
significant wound contraction and accelerated 
closure and healing in mice. These results lend 
some support to the traditional use of ginseng 
root to treat skin diseases. However, more work 
is required to unravel the possible mechanisms 
involved in the process of wound healing, 
whether it is by regulating the body’s immune 
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